scispace - formally typeset
S

Stephan F. Taylor

Researcher at University of Michigan

Publications -  201
Citations -  18385

Stephan F. Taylor is an academic researcher from University of Michigan. The author has contributed to research in topics: Cognition & Prefrontal cortex. The author has an hindex of 58, co-authored 179 publications receiving 16611 citations. Previous affiliations of Stephan F. Taylor include United States Department of Veterans Affairs & Veterans Health Administration.

Papers
More filters
Journal ArticleDOI

Abnormal GABAergic function and face processing in schizophrenia: A pharmacologic-fMRI study.

TL;DR: The altered response to LRZ challenge suggests that abnormal face processing and negative affect in SZ are associated with altered GABAergic function in the visual cortex, underscoring the role of impaired visual processing in socio-emotional deficits in schizophrenia.
Journal ArticleDOI

Neuropsychological function and REM sleep in schizophrenic patients.

TL;DR: REM sleep measures demonstrated positive and negative correlations with cognition and memory measures, depending on when REM occurred after sleep onset, which should test whether phasic REM sleep regulation at the beginning of the night plays a compensatory role for neuropsychological dysfunction in schizophrenics.
Journal ArticleDOI

Eye gaze perception in bipolar disorder: Self-referential bias but intact perceptual sensitivity.

TL;DR: A critical social cognitive process—eye gaze perception—is characterized and its functional correlates in bipolar disorder are examined to inform psychopathological mechanisms.
Journal ArticleDOI

The typical development of posterior medial frontal cortex function and connectivity during task control demands in youth 8-19 years old

TL;DR: Findings suggest differential development of pre-SMA and dACC sub-regions within the pMFC, as children age, may couple with increases in pre- SMA-AI/FO connectivity to support gains in processing speed in response to demands for task control.
Journal Article

Technetium-99m-N1-(2-Mercapto-2-Methylpropyl)-N2-(2-Propargylthio-2-Methylpropyl)-1,2-Benzenediamine (T691): Preclinical Studies of a Potential New Tracer of Regional Cerebral Perfusion

TL;DR: In vitro and in vivo preclinical studies of a new cerebral blood flow tracer, [99mTc]T691, demonstrate promise as a potential new clinical tracer of cerebral perfusion and accumulates regionally in the brain in a pattern consistent with that of cerebralBlood flow.